Tempol Treatment Inhibits Inflammatory Process in Early and Late-stage of Prostate Cancer through TLR4/MyD88/NFkB pathway: in vivo and in vitro assays
- Autor: Isabela Maria Urra Rossetto
Co-autores:
Felipe Rabelo dos Santos
Larissa Akemi Kido
Celina de Almeida Lamas
Valéria Helena Alves Cagnon
- Palavras-chave: cancer, Inflammation, prostate, Tempol
Relacionados
Áreas
Menu